LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...

LVR-KLINIKUM DÜsseLDORF – hOsPITaL OF The heINRIch-heINe UNIVeRsITY DÜsseLDORF
Team meeting of the Research Group „Transcranial Magnetic Stimulation“
experiences from clinical practice lead to the assumption
that there is a rather positive view of rTMS, although this has
not yet been systematically investigated.
A representative telephone survey was carried out in
Germany in which 754 people were asked about their
attitude towards antipsychotic depot medication. The mean
age of the participants was 49.4 years, and 46.9% were
male. 54.1% had experience with taking drugs over a period
of more than 3 months, 27.7% knew people with mental
disorders and 6.4% had a mental disorder themselves. This
questionnaire survey was constructed to elucidate the rather
critical attitudes towards psychotropic depot medication.
The study investigates the causes of and factors influencing
the lack of acceptance of antipsychotic depot medication in
the general population and in those groups of persons who
come into direct or indirect contact with psychotropic drugs.
110
Repetitive transcranial magnetic stimulation (rTMS)
for the treatment of the negative symptoms of
schizophrenia (RESIS)
P. Falkai, T. Wobrock, J. Cordes, B. Langguth,
P. Eichhammer, G. Hajak, G. Winterer, W. Wölwer,
M. Arends, C. Ohmann, E. Ben Sliman
Project period: 2007–2010
Financing: German Research Association GRA
(FA 241/10-1), Alpine Biomed
This is a multicentre GRA project to evaluate the therapeutic
effect of high-frequency rTMS treatment on negative
symptoms in people with schizophrenia (Figures 23 to 25).